Cargando…

Human Milk Oligosaccharides Support Normal Bowel Function and Improve Symptoms of Irritable Bowel Syndrome: A Multicenter, Open-Label Trial

INTRODUCTION: Treatment options for irritable bowel syndrome (IBS) are limited, causing many patients to remain symptomatic. This study assessed the potential of human milk oligosaccharides (HMOs) to normalize bowel habits. Secondary outcomes included IBS severity and health-related quality of life....

Descripción completa

Detalles Bibliográficos
Autores principales:	Palsson, Olafur S., Peery, Anne, Seitzberg, Dorthe, Amundsen, Ingvild Dybdrodt, McConnell, Bruce, Simrén, Magnus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721220/ https://www.ncbi.nlm.nih.gov/pubmed/33512807 http://dx.doi.org/10.14309/ctg.0000000000000276

Ejemplares similares

The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome
por: Iribarren, Cristina, et al.
Publicado: (2021)

Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome
por: Lövdahl, Jenny, et al.
Publicado: (2022)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome
por: Sanz Morales, Patricia, et al.
Publicado: (2022)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
por: Bennet, Sean M.P., et al.
Publicado: (2015)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence
por: Algera, Joost, et al.
Publicado: (2019)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
por: Melchior, Chloé, et al.
Publicado: (2022)

Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome
por: Josefsson, Axel, et al.
Publicado: (2022)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Development of an educational intervention for patients with Irritable Bowel Syndrome (IBS) – a pilot study
por: Ringström, Gisela, et al.
Publicado: (2009)

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome
por: Ahluwalia, Bani, et al.
Publicado: (2021)

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
por: Melchior, Chloé, et al.
Publicado: (2022)

Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms
por: Midenfjord, Irina, et al.
Publicado: (2020)

Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial
por: Gaylord, Susan A, et al.
Publicado: (2009)

Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar
por: Kovács, Dénes Botond, et al.
Publicado: (2022)

Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome
por: Nybacka, Sanna, et al.
Publicado: (2020)

Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome
por: Tap, Julien, et al.
Publicado: (2021)

Fasting breath H(2) and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome
por: Le Nevé, Boris, et al.
Publicado: (2019)

The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options
por: Nybacka, Sanna, et al.
Publicado: (2022)

Low fermentable oligosaccharides, disaccharides, monosaccharides, and polypols diet and irritable bowel syndrome in Asia
por: Zhang, Yihe, et al.
Publicado: (2018)

Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome
por: Colomier, Esther, et al.
Publicado: (2022)

Changes in serum and urinary metabolomic profile after a dietary intervention in patients with irritable bowel syndrome
por: Nybacka, Sanna, et al.
Publicado: (2021)

Randomised controlled trial: effects of gluten‐free diet on symptoms and the gut microenvironment in irritable bowel syndrome
por: Algera, Joost P., et al.
Publicado: (2022)

Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
por: Tack, Jan, et al.
Publicado: (2019)

Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia
por: Kanazawa, Motoyori, et al.
Publicado: (2015)

Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome
por: Frändemark, Åsa, et al.
Publicado: (2022)

Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome
por: Algera, Joost P., et al.
Publicado: (2022)

Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J)
por: Kanazawa, Motoyori, et al.
Publicado: (2007)

Galacto-oligosaccharides and bowel function
por: Niittynen, Leena, et al.
Publicado: (2007)

The Serum Metabolite Response to Diet Intervention with Probiotic Acidified Milk in Irritable Bowel Syndrome Patients Is Indistinguishable from that of Non-Probiotic Acidified Milk by (1)H NMR-Based Metabonomic Analysis
por: Pedersen, Simon M. M., et al.
Publicado: (2010)

Defining the irritable bowel
por: Chuah, Kee Huat, et al.
Publicado: (2022)

Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice
por: Simren, Magnus, et al.
Publicado: (2017)

Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids
por: Iribarren, Cristina, et al.
Publicado: (2022)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

Increased Postprandial Colonic Motility and Autonomic Nervous System Activity in Patients With Irritable Bowel Syndrome: A Prospective Study
por: Tanaka, Yukari, et al.
Publicado: (2018)

Association between pain sensitivity and gray matter properties in the sensorimotor network in women with irritable bowel syndrome
por: Grinsvall, Cecilia, et al.
Publicado: (2020)

Irritable bowel syndrome, inflammatory bowel disease and the microbiome
por: Major, Giles, et al.
Publicado: (2014)

Is irritable bowel syndrome a dysbiotic bowel syndrome?
por: Benno, Peter, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ipj1173nmbejl7fb97pbtjvl41